Supplier

GENOMIC HEALTH INC SEDE SECONDARIA N MI1

Value won

€819k

Across 1 contract won

A Italy supplier, with 1 awarded contract, most recently 17 months ago.

Italy(inferred)

Track GENOMIC HEALTH INC SEDE SECONDA…

We'll email you when they win a contract · Free · No card

Value won

€819k

Across 1 contract won

Contract history

1 entry

16 June 2025

17 months ago · Won · £819,000 · Genomic Profiling Tests for Early Stage…

Opportunities

Showing awarded · 1

AwardedHealthcare & MedicalItaly

Genomic Profiling Tests for Early Stage HER2-Negative Luminal Breast Cancer Patients

This contract involves the execution and reporting of genomic profiling tests specifically for patients diagnosed with early-stage invasive luminal HER2-negative breast cancer. The aim is to provide accurate genomic data that can assist in the treatment planning and management of these patients. The

€819,000ORG0001

Published 16 Jun 2025